International Bordetella Symposia
国际博德特氏菌研讨会
基本信息
- 批准号:10469207
- 负责人:
- 金额:$ 0.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-06-26 至 2023-05-31
- 项目状态:已结题
- 来源:
- 关键词:AcademiaAddressAdvertisingAntibiotic ResistanceAwardBacteriaBacterial InfectionsBordetellaBordetella pertussisBritish ColumbiaCOVID-19 pandemicCanadaCenters for Disease Control and Prevention (U.S.)Cessation of lifeChildClinicalCollaborationsCommunitiesDevelopmentEpidemiologyEventFosteringFunctional disorderFundingFunding OpportunitiesFutureGoalsHealthIncidenceIndividualInfectionInternationalLifeManufacturer NameMarylandMicrobiologyMinority WomenMissionNotificationParticipantPertussisPertussis VaccinePharmacologic SubstancePostdoctoral FellowPreventionPrivatizationProcessPublic HealthReportingResearchResearch PersonnelRespiratory DiseaseRespiratory Tract InfectionsScientistSeriesSocietiesStudentsTrainingTravelUnderrepresented MinorityUnited States National Institutes of HealthUniversitiesVaccinesWomanbasecostdata disseminationdata exchangegraduate studentinnovationinvestigator trainingmeetingsnext generationpathogenpathogenic bacteriapre-doctoralpreventable deathresearch and developmentsuccesssymposiumtranslational scientistundergraduate studentvaccine development
项目摘要
Project Summary/Abstract:
Whooping cough, also known as Pertussis, is a respiratory disease caused by the bacterial pathogen Bordetella
pertussis. Pertussis is one of the world’s leading causes of vaccine-preventable deaths and is currently the only
vaccine-preventable bacterial disease that is increasing in incidence. Despite high vaccine coverage, whooping
cough (pertussis) has re-emerged as a major public health concern in the US and the world. Recently, it was
estimated that there were 24 million pertussis cases and 160,700 deaths in children younger than 5 years around
the world per year. In addition to being added to the NIH emerging infectious pathogens list in 2015, the CDC
recently listed Bordetella pertussis on its new Watch List in the 2019 Antibiotic Resistance Threats Report
because of the unknown future burden of this highly contagious bacterium. Since the 1960’s, the Bordetella
research community has organized an International Bordetella Symposium, the 12th symposium was hosted at
Brussels University by Dr. Camille Locht, in April of 2019. In an effort to increase dissemination of new data and
exchange of ideas, Dr. Ciaran Skerry hosted the 1st ever Bordetella Research Day at the University of Maryland
in April, 2018. The Bordetella Research Day was meant to be a U.S-based conference for Bordetella researchers
to meet during the off years of the International Bordetella Symposiums. Due to the COVID-19 pandemic, both
the 2020 Bordetella Research Day, and the 2021 International Bordetella Symposium were postponed. To
continue dissemination of important research, the International Bordetella Society hosted a zoom-based
conference in August 2020 which garnered attendance from academia, the CDC, FDA, NIH, and many
pharmaceutical companies. The major success of this online event resulted in the Bordetella Society creating a
monthly Lab Meeting Series, where different groups around the world can showcase their latest research. In
order to further support the development of the next generation of scientists, this R13 application is requesting
funds to support travel associated costs for junior scientists (pre- and post-doctoral) to attend and present
innovative research at the 13th International Bordetella Symposium hosted at the University of British Columbia
in Vancouver, Canada (June 2022).
项目摘要/摘要:
百日咳,也称为百日咳,是一种由细菌病原体博德特氏菌引起的呼吸道疾病
百日咳。百日咳是世界上疫苗可预防的死亡的主要原因之一,也是目前唯一的
疫苗可预防的细菌性疾病的发病率正在增加。尽管疫苗覆盖率很高,但百日咳
咳嗽(百日咳)已重新成为美国和世界的主要公共卫生问题。最近,它是
据估计,大约有 2,400 万例百日咳病例,其中 160,700 例 5 岁以下儿童死亡
每年的世界。除了 2015 年被添加到 NIH 新发传染性病原体清单中外,CDC
最近将百日咳博德特氏菌列入 2019 年抗生素耐药性威胁报告的新观察名单
因为这种高度传染性细菌的未来负担未知。自 20 世纪 60 年代以来,博德特氏菌
研究界组织了国际博德特氏菌研讨会,第12届研讨会在
布鲁塞尔大学,作者:Camille Locht 博士,2019 年 4 月。为了加强新数据和
交流思想,Ciaran Skerry 博士在马里兰大学主持了第一届博德特氏菌研究日活动
2018 年 4 月。博德特氏菌研究日原本是为博德特氏菌研究人员在美国举办的会议
在国际博德特氏菌研讨会休会期间举行。由于 COVID-19 大流行,
2020年博德特氏菌研究日和2021年国际博德特氏菌研讨会被推迟。到
继续传播重要研究成果,国际博德特氏菌协会主办了基于变焦的
2020 年 8 月举行的会议吸引了学术界、疾病预防控制中心 (CDC)、FDA、美国国立卫生研究院 (NIH) 和许多机构的参加
制药公司。这次在线活动取得了巨大成功,博德特氏菌协会创建了一个
每月一次的实验室会议系列,世界各地的不同团体可以展示他们的最新研究成果。在
为了进一步支持下一代科学家的发展,这个R13应用程序要求
用于支持年轻科学家(博士前和博士后)出席和演讲的差旅相关费用的资金
在不列颠哥伦比亚大学主办的第十三届国际博德特氏菌研讨会上的创新研究
加拿大温哥华(2022 年 6 月)。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Fredrick Heath Damron其他文献
Fredrick Heath Damron的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Fredrick Heath Damron', 18)}}的其他基金
Development of mucosal vaccines to protect against pertussis
开发预防百日咳的粘膜疫苗
- 批准号:
10333333 - 财政年份:2019
- 资助金额:
$ 0.5万 - 项目类别:
Development of mucosal vaccines to protect against pertussis
开发预防百日咳的粘膜疫苗
- 批准号:
10548222 - 财政年份:2019
- 资助金额:
$ 0.5万 - 项目类别:
Development of mucosal vaccines to protect against pertussis
开发预防百日咳的粘膜疫苗
- 批准号:
10084257 - 财政年份:2019
- 资助金额:
$ 0.5万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 0.5万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 0.5万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 0.5万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 0.5万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 0.5万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 0.5万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 0.5万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 0.5万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 0.5万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 0.5万 - 项目类别:
Research Grant